Lack of tolerance development with long-term administration of PEGylated cholecystokinin

Peptides

Volumn 30, Issue 4, 2009, Pages 699-704

  Verbaeys, Isabelle ^a   León Tamariz, Fabián ^b   Buyse, Johan ^c   Decuypere, Eddy ^c   Pottel, Hans ^a   Cokelaere, Marnix ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Cuenca University   (Ecuador)

^c LABORATORY OF GENE TECHNOLOGY   (Belgium)

Author keywords

Cholecystokinin; Long term administration; Pancreas proliferation; PEGylated Cholecystokinin; Satiety; Tolerance

Indexed keywords

AMYLASE; CHOLECYSTOKININ; DNA; TRIACYLGLYCEROL LIPASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG INHIBITION; ENZYME BLOOD LEVEL; FOOD INTAKE; HYPERPLASIA; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ANIMALS; BODY WEIGHT; CHOLECYSTOKININ; DRUG TOLERANCE; FEEDING BEHAVIOR; INJECTIONS, INTRAPERITONEAL; KIDNEY FUNCTION TESTS; LIVER FUNCTION TESTS; MALE; PANCREAS; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 62749197307     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.11.010     Document Type: Article

References (42)

1. Abuchowski A., van Es T., Palczuk N.C., and Davis F.F. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 252 (1977) 3578-3581
2. Bado A., Rodriguez M., Lewin M.J., Martinez J., and Dubrasquet M. Cholecystokinin suppresses food intake in cats: structure-activity characterization. Pharmacol Biochem Behav 31 (1988) 297-303
3. Baldwin B.A., Cooper T.R., and Parrott R.F. Intravenous cholecystokinin octapeptide in pigs reduces operant responding for food, water, sucrose solution or radiant heat. Physiol Behav 30 (1983) 399-403
4. Baldwin B.A., Parrott R.F., and Ebenezer I.S. Food for thought: a critique on the hypothesis that endogenous cholecystokinin acts as a physiological satiety factor. Prog Neurobiol 55 (1998) 477-507
5. Baldwin G.S. The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth. J Gastroenterol Hepatol 10 (1995) 215-232
6. Beglinger C. Potential role of cholecystokinin in the development of acute pancreatitis. Digestion 60 Suppl. 1 (1999) 61-63
7. Crawley J.N., and Beinfeld M.C. Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature 302 (1983) 703-706
8. Deupree D., and Hsiao S. Cholecystokinin octapeptide, proglumide, and conditioned taste avoidance in rats. Physiol Behav 41 (1987) 125-128
9. Deutsch J.A., and Hardy W.T. Cholecystokinin produces bait shyness in rats. Nature 266 (1977) 196
10. Dockray G.J. The action of secretin, cholecystokinin-pancreozymin and caerulein on pancreatic secretion in the rat. J Physiol 225 (1972) 679-692
11. Ervin G.N., Birkemo L.S., Johnson M.F., et al. The effects of anorectic and aversive agents on deprivation-induced feeding and taste aversion conditioning in rats. J Pharmacol Exp Ther 273 (1995) 1203-1210
12. Ervin G.N., and Teeter M.N. Cholecystokinin octapeptide and lithium produce different effects on feeding and taste aversion learning. Physiol Behav 36 (1986) 507-512
13. Gibbs J., Young R.C., and Smith G.P. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84 (1973) 488-495
14. Goodman L.S., and Gilman A. The pharmacological basis of therapeutics. 4th ed. (1970), The Macmillan Company, New York
15. Harris J.M., and Chess R.B. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2 (2003) 214-221
16. Harris J.M., Martin N.E., and Modi M. Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet 40 (2001) 539-551
17. Keith H.M., Zarzaur Jr. B.L., Fukatsu K., Chance D.R., Renegar K.B., Sherrell C., et al. Individual neuropeptides regulate gut-associated lymphoid tissue integrity, intestinal immunoglobulin A levels, and respiratory antibacterial immunity. J Parenter Enteral Nutr 24 (2000) 261-268
18. Kissileff H.R., Pi-Sunyer F.X., Thornton J., and Smith G.P. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr 34 (1981) 154-160
19. Labarca C., and Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102 (1980) 344-352
20. Léon-Tamariz F., Verbaeys I., Van Boven M., et al. PEGylation of cholecystokinin prolongs its anorectic effect in rats. Peptides 28 (2007) 1003-1011
21. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
22. Lukaszewski L., and Praissman M. Effect of continuous infusions of CCK-8 on food-intake and body and pancreatic weights in rats. Am J Physiol 254 (1988) R17-R22
23. Mineka S., and Snowdon C.T. Inconsistency and possible habituation of CCK-induced satiety. Physiol Behav 21 (1978) 65-72
24. Moore B.O., and Deutsch J.A. An antiemetic is antidotal to the satiety effects of cholecystokinin. Nature 315 (1985) 321-322
25. Niederau C., and Grendell J.H. Role of cholecystokinin in the development and progression of acute pancreatitis and the potential of therapeutic application of cholecystokinin receptor antagonists. Digestion 60 Suppl. 1 (1999) 69-74
26. Niederau C., Liddle R.A., Ferrell L.D., and Grendell J.H. Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. J Clin Invest 78 (1986) 1056-1063
27. Ohlsson B., Axelson J., Sternby B., Rehfeld J.F., and Ihse I. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor. Int J Pancreatol 18 (1995) 59-66
28. Ohlsson B., Borg K., Mulder H., et al. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas. Scand J Gastroenterol 35 (2000) 612-618
29. Ohlsson B., Borg K., Rehfeld J.F., Axelson J., and Sundler F. The method of administration of cholecystokinin determines the effects evoked in the pancreas. Pancreas 23 (2001) 94-101
30. Perez C., and Sclafani A. Cholecystokinin conditions flavor preferences in rats. Am J Physiol 260 (1991) R179-R185
31. Roberts M.J., Bentley M.D., and Harris J.M. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 54 (2002) 459-476
32. Savory C.J., and Gentle M.J. Intravenous injections of cholecystokinin and caerulein suppress food intake in domestic fowls. Experientia 36 (1980) 1191-1192
33. Trulsson L.M., Svanvik J., Permert J., and Gasslander T. Cholecystokinin octapeptide induces both proliferation and apoptosis in the rat pancreas. Regul Pept 98 (2001) 41-48
34. Vanderweele D.A., Oetting R.L., Jones R.E., and Deems D.A. Sham feeding, flavor associations and diet self-selection as indicators of feeding satiety or aversive effects of peptide hormones. Brain Res Bull 14 (1985) 529-535
35. Vaysse N., Laval J., Duffaut M., and Ribet A. Effect of secretin and graded doses of CCK-PZ on pancreatic secretion in man. Am J Dig Dis 19 (1974) 887-894
36. Verbaeys I., Léon-Tamariz F., Buyse J., et al. PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement. Br J Pharmacol 152 (2007) 396-403
37. Verbaeys I., Léon-Tamariz F., Pottel H., et al. PEGylated cholecystokinin is more potent in inducing anorexia than conditioned taste aversion in rats. Br J Pharmacol 155 (2008) 417-423
38. Veronese F.M., and Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today 10 (2005) 1451-1458
39. West D.B., Fey D., and Woods S.C. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol 246 (1984) 776-787
40. West D.B., Greenwood M.R., Marshall K.A., and Woods S.C. Lithium chloride, cholecystokinin and meal patterns: evidence that cholecystokinin suppresses meal size in rats without causing malaise. Appetite 8 (1987) 221-227
41. Yamamoto M., Otani M., Jia D.M., et al. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats. Am J Physiol-Gastroint Liver Physiol 285 (2003) 681-687
42. Zarbin M.A., Wamsley J.K., Innis R.B., and Kuhar M.J. Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve. Life Sci 29 (1981) 697-705